My Account Log in

1 option

Genentech : the beginnings of biotech / Sally Smith Hughes.

Lippincott Library HD9999.B444 H85 2011
Loading location information...

By Request Item cannot be checked out at the library but can be requested.

Log in to request item
Format:
Book
Author/Creator:
Hughes, Sally Smith, author.
Series:
Synthesis (University of Chicago. Press)
Synthesis
Language:
English
Subjects (All):
Genentech, Inc--History.
Genentech, Inc.
Biotechnology industries--United States--History.
Biotechnology industries.
Biotechnology--History.
Biotechnology.
History.
United States.
Physical Description:
xv, 213 pages : illustrations ; 24 cm.
Place of Publication:
Chicago : University of Chicago Press, 2011.
Summary:
This volume on the nexus of corporate and scientific history explores the field of biotechnology through the story of Genetech, the first successful and lucrative startup corporation in the field. The work examines the people and policies behind Genetech's rise and discusses key issues regarding the separation of science and business, the ethics of healthcare based corporations, and the technology sector as a viable market engine. Hughes is a historian of science at the Bancroft Library, University of California, Berkeley. Annotation ©2011 Book News, Inc., Portland, OR (booknews.com)
Contents:
1. Inventing recombinant DNA technology ; Scientists on converging paths ;The collaboration ; Patenting and politics ; Steps toward commercialization
2. Creating Genentech ; Bob Swanson ; Founding Genentech ; Legal and political obstacles ; A full business plan
3. Proving the technology ; A portentous experiment ; Switching targets ; Negotiating research agreements
Making somatostatin ; Wider issues
4. Human insulin: Genentech makes its mark ; Seeking corporate contracts; Procuring a facility and staff ; Genentech's human insulin project ; The Eli Lilly contract ; Publicity and expansion
5. Human growth hormone: shaping a commercial future ; Competing for human growth hormone ; Moving toward corporate integration ; Scaling up insulin and growth hormone ; Corporate expansion ; An emerging culture
6. Wall Street debut ; Biomania ; Exit strategies ; Interferon: the new wonder drug? ; Run-up to an initial public offering ; Legal impediments ; The IPO.
Notes:
Includes bibliographical references and index.
ISBN:
9780226359182
0226359182
OCLC:
701242603

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account